Entia Biosciences, Inc. (ERGO) Research

Entia Biosciences, Inc. (ERGO) is a U.S.-based company primarily engaged in the development, manufacturing, and distribution of dietary supplements, nutraceuticals, and medical food products. The company also dedicates efforts to discovering, scientifically evaluating, and marketing natural formulations for various applications, including medical foods, nutraceuticals, and cosmetics. Its product portfolio features significant formulations like ErgoD2, a pharmaceutical-grade organic compound derived from whole foods, which contains essential micronutrients. Other key components include L-Ergothioneine, a naturally occurring amino acid known for its powerful antioxidant properties, and vitamin D, also an antioxidant. Beyond these offerings, Entia is actively developing solutions for chronic kidney disease and other health conditions, while also marketing cosmeceuticals and beauty products under its GROH brand. The company distributes its products directly to consumers through various e-commerce channels, such as email marketing, social media platforms, and its own online stores. Founded in 2007 and headquartered in Sherwood, Oregon, the company was initially known as Total Nutraceutical Solutions, Inc. before rebranding as Entia Biosciences, Inc. in January 2012.

Open Entia Biosciences, Inc. (ERGO) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.